Table 1.
Classification | No. of studies (n = 258) |
---|---|
Study type | |
Systematic Review or Meta-Analysis | 15 |
Longitudinal | 46 |
Experimental | 46 |
Qualitative | 79 |
Observational | 141 |
Primary themes included | |
Social media | 18 |
Toxicity | 22 |
Health effects | 34 |
Other | 34 |
Addiction | 39 |
Transitions in use | 42 |
Marketing | 59 |
Trajectories of use | 60 |
Dual/poly use | 63 |
Communications | 73 |
Psychosocial risk factors | 89 |
Sociodemographic factors | 124 |
Prevalence of tobacco use | 144 |
Specific tobacco product use | 177 |
FDA priorities directly addressed | |
Impact analysis | 18 |
Toxicity | 22 |
Health effects | 33 |
Addiction | 45 |
Marketing influences | 53 |
Communications | 62 |
Behavior | 206 |
CENIC = Center for the Evaluation of Nicotine in Cigarettes; COMET = Consortium on Methods Evaluating Tobacco; FDA = Food and Drug Administration; TCORS = Tobacco Centers of Regulatory Science.
aClassifications of articles in each category are not mutually exclusive.